Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Getting Your Youngsters' Future: Grasping Legacy Regulations - 2NASA’s Artemis II launch leaves Americans in awe: ‘We’re going to the frickin’ moon!’
- 3The most effective method to Engage in Local area Making arrangements for 5G Pinnacle Establishments
- 4The Best Games On the planet
- 5Step by step instructions to Guarantee Your Internet Promoting Degree Supplements Your Profession Objectives
- 'Stranger Things' Season 5: When does Volume 2 come out? And Volume 3? Everything to know about the remaining episodes before the finale.
- The 10 Most Significant Virtual Entertainment Missions
- Inside the alleged Russian operation to trigger anti-government protests in Angola
- German Cabinet advances bill to cut greenhouse emissions from fuels
- The most effective method to Decisively Use Open Record Rewards
- What were the little white pills found in Tiger Woods's pocket at the scene of his crash? What to know about hydrocodone.
- Europe pledges over €15bn for clean energy for Africa
- Hundreds are quarantined in South Carolina as measles spreads in 2 US outbreaks
- Holocaust survivor, descendants urge High Court to allow Gaza children medical access
